Revance Therapeutics | 贷款资金

Loan Capital 更改 日
ALKERMES USD 288.37M 635K 2023-09
Eli Lilly USD 17.92B 956.9M 2023-09
Neurocrine Biosciences USD 169.5M 500K 2023-03
Pacira USD 513.8M 2.14M 2023-12
Supernus Pharmaceuticals USD 0 400.38M 2022-06



Revance Therapeutics 贷款资金 - 当前值，历史数据，预测，统计，图表和经济日历 - Apr 2024.